Clinical Trial Update: Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Kanglaite Gelcaps for prostate cancer has been terminated; the update reports safety and efficacy observations from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Kanglaite Gelcaps

Snippet

Sponsor: KangLaiTe USA | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED